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Methods

Search String
The following search string was used (with minor amendments for the specific databases) to identify potential studies published in peer reviewed journals and indexed in PubMed, EMBASE 
Study Selection criteria
The selection criteria used were that the study provided: 1) estimates for PM2.5; 2) at least one year of daily data relating to a general population; 3) a reasonable attempt to control for important confounding factors such as season, long-term temporal trends and meteorological conditions and 4) sufficient information for the calculation of a regression estimate and standard error for comparison in the quantitative analysis. No limitation was placed upon language. We also cross-checked our search results against publications selected for other reviews.
Lag selection protocol
The short-term relationships between air pollution and health effects are characterised by the time lag (in days) between exposure and health events and investigators vary in which lags they study and report. This means that the use of any particular lag would result in the exclusion of many other studies. In the absence of a standard method of reporting the lag, we therefore adopted the following approach for selecting lag results for inclusion in the database. If only one lagged estimate for a given pollutant/outcome pair was presented (either because only one was analysed or only one was reported in the paper), this estimate was recorded in the Access database for the outcome-pollutant pair. If more than one lag measure was presented, we selected one for meta-analysis according to the following algorithm: 1) the lag that the author focused on or stated a priori; 2) the lag that was the most statistically significant (positive or negative) and 3) the lag with the largest effect estimate (positive or negative). For options 2) and 3) results for single lags were selected ahead of results for cumulative/distributed lags.
Estimate selection protocol
Furthermore, numerous multi-city studies have incorporated the same cities more than once.
Inclusion of results from a single-city more than once in a meta-analysis was not appropriate as the study populations will be correlated and the over-representation of a single-city may bias the summary estimate. Hence, we selected estimates from single-city studies only if they did not appear in multi-city studies. If a city was the subject of a single-city study on more than one occasion we took the result for the most recent publication. Where results from more than one multi-city study within a WHO Region were available we selected, in order of priority, the multicity study: 1) with the most cities/greatest geographical coverage; 2) the most recently published; and 3) the longest study period. 
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